Palvella Therapeutics, Inc (PVLA) — Cash Flow Quality Index
Palvella Therapeutics, Inc (PVLA) has a Cash Flow Quality Index of -0.73x as of December 2023. Operating cash flow of $-13.70 Million is below net income of $18.69 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Palvella Therapeutics, Inc (PVLA) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Palvella Therapeutics, Inc Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Palvella Therapeutics, Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Palvella Therapeutics, Inc (PVLA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Quality Index for Palvella Therapeutics, Inc (2023–2023)
Year-by-year earnings quality comparison for Palvella Therapeutics, Inc. For live market cap and the full company financial profile, see Palvella Therapeutics, Inc stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.73x | $-13.70 Million | $18.69 Million | — |